Watson Pharmaceuticals, Inc. announced Tuesday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the U.S. is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are from Lot Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. The affected lot of Fentanyl Transdermal System patches was shipped to customers between April 2, 2009 and May 20, 2009. No other...
What Is Actiq Fentanyl 800 Mcg?
Featured Health Expert
More information on "What Is Actiq Fentanyl 800 Mcg?"
From Our Experts
EXPERT
Fentanyl Patch Recall Expanded
By Karen Lee Richards, Health Expert
Two weeks ago we told you that the 25mcg/hr fentanyl transdermal system patches (also known as Duragesic patches) were being recalled due... Read more »
EXPERT
Duragesic 25 mcg/hr Pain Patch Recalled
By Karen Lee Richards, Health Expert
The FDA reports that PriCara and Sandoz, Inc. have announced a voluntary nationwide recall of all lots of 25 mcg/hr Duragesic Patches... Read more »
EXPERT
FDA Approves REMS for Transmucosal Immediate-Release Fentanyl Meds
By Karen Lee Richards, Health Expert
Since 2007, the FDA has been discussing and debating the development of Risk Evaluation and Mitigation Strategies (REMS) for opioid... Read more »
EXPERT
More Than One Million Fentanyl Patches Recalled
By Karen Lee Richards, Health Expert
Late yesterday Actavis Inc. announced a voluntary recall of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches manufactured... Read more »
EXPERT
Stalking Byetta
By David Mendosa, Health Expert
Taking Byetta is a lot easier than getting it. At least for me. Byetta (pronounced bye-A-tuh) has been an interest of mine for years. I... Read more »
From Our Sources
Actiq better than other narcotics on breakthrough pain
A study at the St. Clare Hospice in England has found that Actiq is more effective than other narcotics in controlling breakthrough pain in cancer... Read more »
FDA approves generic form of Duragesic
Drugmaker Teva has announced that the U.S. Food and Drug Administration has approved its generic form of the pain patch Duragesic for sale in the... Read more »
Breakthrough Pain
Source: Breastcancer.org
Supplemental opioid (pronounced OH-pee-oyd) medication is used for breakthrough pain. The opioid is taken in addition to the medication prescribed... Read more »
TMJ Medications
There are no specific medications made for TMJ disorder, so drugs can only be prescribed to treat the symptoms. Symptoms of TMJ disorder vary... Read more »
Moderate to Severe Persistent Pain
Source: Breastcancer.org
Narcotics, or opioids (pronounced OH-pee-oydz), provide the main relief for this level of pain. There are both long-acting and short-acting opioid... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
